PHARMACOLOGIC MANAGEMENT OF SEXUALLY TRANSMITTED DISEASES

Authors

  • Valerie A. Roe MS, CNM,

    Corresponding authorSearch for more papers by this author
    • Valerie A. Roe is a 1984 graduate of the nurse-midwifery program at the State University of New York, Health Science Center at Brooklyn (SUNY HSCB). She obtained a master of science degree from SUNY at Stonybrook in 1995. Her clinical experience includes 12 years of full-scope midwifery practice, primarily in underserved areas. She is a full-time faculty member within the SUNY HSCB Midwifery Education Program.

  • Anne Gudi MS, CNM

    Search for more papers by this author
    • Anne Gudi is a 1992 graduate of the SUNY HSCB Nurse-Midwifery Program. She received a master of science degree from Wagner College in 1986 and taught maternal child nursing at the college level for several years before becoming a midwife. She is a former faculty member of SUNY HSCB and currently is a partner in Park Slope Midwifery Associates, practicing full-scope midwifery.


Valerie A. Roe, MS, CNM, Midwifery Education Program, State University of New York, Health Science Center at Brooklyn, 450 Clarkson Avenue, Box 1227, Brooklyn, NY 11203–2098.

ABSTRACT

Vaginal complaints account for a significant proportion of visits to health care providers and are an ongoing challenge to every clinician in terms of diagnosis and management. Midwives traditionally have viewed such complaints as a disruption of the vaginal ecosystem and have adopted a combination of pharmacologic and nonpharmacologic treatment modalities in the management of vulvovaginitis and sexually transmitted diseases.

This article presents a review of the literature that focuses primarily on the pharmacologic management of some of the more common sexually transmitted diseases. The management of vulvovaginal candidiasis and bacterial vaginosis also is reviewed. Although neither condition is sexually transmitted, they always should be considered in the differential diagnosis of vaginal complaints.

Ancillary